Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Nasdaq - Delayed Quote USD

Invenomic Institutional (BIVIX)

17.98
-0.13
(-0.72%)
At close: March 28 at 8:00:07 PM EDT
Loading Chart for BIVIX
  • Previous Close 18.11
  • YTD Return 0.23%
  • Expense Ratio 3.17%
  • Category Long-Short Equity
  • Last Cap Gain -19.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 1.13B
  • Beta (5Y Monthly) 0.08
  • Yield 3.95%
  • 5y Average Return --
  • Holdings Turnover 170.00%
  • Last Dividend 0.68
  • Inception Date May 10, 2019

The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years ("unseasoned issuers") and in initial public offerings of securities ("IPO").

Invenomic

Fund Family

Long-Short Equity

Fund Category

1.13B

Net Assets

2019-05-10

Inception Date

Performance Overview: BIVIX

View More

Trailing returns as of 3/28/2025. Category is Long-Short Equity.

YTD Return

BIVIX
0.23%
Category
9.18%
 

1-Year Return

BIVIX
1.45%
Category
22.90%
 

3-Year Return

BIVIX
8.51%
Category
7.45%
 

5-Year Return

BIVIX
26.57%
Category
7.00%
 

People Also Watch

Holdings: BIVIX

View More

Sector Weightings

SectorBIVIX
Technology   22.09%
Healthcare   10.15%
Industrials   10.13%
Energy   6.75%
Utilities   2.88%
Real Estate   0.46%

Recent News: BIVIX

View More

Research Reports: BIVIX

View More

Top Mutual Funds